Helix BioPharma Corp.

Helix BioPharma Corp.verified

HBPCF

Price:

$1.73

Market Cap:

$174.14M

Helix BioPharma Corp. operates as an immune-oncology company in Canada. The company is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. It has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. The company is headquartered in Toronto, Canada.

Industry

Biotechnology

IPO Date

2009-11-27

Stock Exchange

OTC

Ticker

HBPCF

The Current Ratio as of January 2026 (TTM) for Helix BioPharma Corp. (HBPCF) is 0.23

According to Helix BioPharma Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 0.23. This represents a change of -48.78% compared to the average of 0.44 of the last 4 quarters.

Helix BioPharma Corp. (HBPCF) Historical Current Ratio (quarterly & annually)

How has HBPCF Current Ratio performed in the past?

The mean historical Current Ratio of Helix BioPharma Corp. over the last ten years is 1.06. The current 0.23 Current Ratio has changed 2.02% with respect to the historical average. Over the past ten years (40 quarters), HBPCF's Current Ratio was at its highest in in the January 2021 quarter at 3.95. The Current Ratio was at its lowest in in the July 2025 quarter at 0.13.

Quarterly (TTM)
Annual

Average

1.06

Median

0.85

Minimum

0.13

Maximum

3.25

Helix BioPharma Corp. (HBPCF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Helix BioPharma Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.39%

Maximum Annual Current Ratio = 3.25

Minimum Annual Increase = -86.21%

Minimum Annual Current Ratio = 0.13

Quarterly (TTM)
Annual
YearCurrent RatioChange
20250.13-86.21%
20240.9273.50%
20230.53-50.94%
20221.084.44%
20211.04-57.16%
20202.421.39%
20190.16-43.70%
20180.29-62.52%
20170.77-76.24%
20163.25-57.87%

Helix BioPharma Corp. (HBPCF) Average Current Ratio

How has HBPCF Current Ratio performed in the past?

The current Current Ratio of Helix BioPharma Corp. (HBPCF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0.53

5-year avg

0.74

10-year avg

1.06

Helix BioPharma Corp. (HBPCF) Current Ratio vs. Peers

How is HBPCF’s Current Ratio compared to its peers?

Helix BioPharma Corp.’s Current Ratio is less than MindMaze Therapeutics Holding S.A. Sponsored ADR (4.05), less than Calliditas Therapeutics AB (publ) (3.13), greater than PsyBio Therapeutics Corp. (0.13), less than Relief Therapeutics Holding AG (4.05), greater than Arch Biopartners Inc. (0.07), less than Amplia Therapeutics Limited (28.17), greater than ZIVO Bioscience, Inc. (0.08), greater than TransCanna Holdings Inc. (0.06), greater than Oncotelic Therapeutics, Inc. (0.08), greater than Vicapsys Life Sciences, Inc. (0.00),

Build a custom stock screener for Helix BioPharma Corp. (HBPCF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Helix BioPharma Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Helix BioPharma Corp. (HBPCF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Helix BioPharma Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Helix BioPharma Corp.'s Current Ratio?

How is the Current Ratio calculated for Helix BioPharma Corp. (HBPCF)?

What is the highest Current Ratio for Helix BioPharma Corp. (HBPCF)?

What is the 3-year average Current Ratio for Helix BioPharma Corp. (HBPCF)?

What is the 5-year average Current Ratio for Helix BioPharma Corp. (HBPCF)?

How does the current Current Ratio for Helix BioPharma Corp. (HBPCF) compare to its historical average?